UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel

Cancer chemotherapy and pharmacology, 2013-09, Vol.72 (3), p.515-528

2013

Volltextzugriff (PDF)

Preclinical evaluation of new taxoids

Current pharmaceutical design, 2001-09, Vol.7 (13), p.1251-1257

Bissery, M C

2001

Volltextzugriff (PDF)

Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma

British journal of cancer, 2002-03, Vol.86 (6), p.999-1005

2002

Volltextzugriff (PDF)

Docetaxel (Taxotere®) a review of preclinical and clinical experience. Part I: preclinical experience

Anti-cancer drugs, 1995-06, Vol.6 (3), p.339-355

1995

Volltextzugriff (PDF)

Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue

Cancer research (Baltimore), 1991-09, Vol.51 (18), p.4845-4852

1991

Volltextzugriff (PDF)

Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination

Cancer research (Chicago, Ill.), 2001-03, Vol.61 (5), p.1996-2001

2001

Volltextzugriff (PDF)

Preclinical pharmacology of docetaxel

European journal of cancer (1990), 1995-01, Vol.31, p.S1-S6

Bissery, M.-C.

1995

Volltextzugriff (PDF)

Syntheses and Structure−Activity Relationships of the Second-Generation Antitumor Taxoids: Exceptional Activity against Drug-Resistant Cancer Cells

Journal of medicinal chemistry, 1996-09, Vol.39 (20), p.3889-3896

1996

Volltextzugriff (PDF)

Preclinical evaluation of docetaxel (Taxotere)

Seminars in oncology, 1995-04, Vol.22 (2 Suppl 4), p.3

1995

Volltextzugriff (PDF)

Preclinical profile of docetaxel (taxotere): efficacy as a single agent and in combination

Seminars in oncology, 1995-12, Vol.22 (6 Suppl 13), p.3

1995

Volltextzugriff (PDF)

Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts

British journal of cancer, 1996-08, Vol.74 (4), p.537-545

1996

Volltextzugriff (PDF)

Tau expression in model adenocarcinomas correlates with docetaxel sensitivity in tumour-bearing mice

British journal of cancer, 1998-10, Vol.78 (7), p.871-877

1998

Volltextzugriff (PDF)

Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

Annals of oncology, 2001-07, Vol.12 (7), p.909-918

2001

Volltextzugriff (PDF)

Docetaxel chronopharmacology in mice

Cancer research (Chicago, Ill.), 1998-09, Vol.58 (17), p.3896-3904

1998

Volltextzugriff (PDF)

Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice

Anti-cancer drugs, 1996-06, Vol.7 (4), p.437-460

1996

Volltextzugriff (PDF)

Proteolysis of microtubule associated protein 2 and sensitivity of pancreatic tumours to docetaxel

British journal of cancer, 2000-08, Vol.83 (4), p.544-549

2000

Volltextzugriff (PDF)

A novel human gene, encoding a potential membrane protein conserved from yeast to man, is strongly expressed in testis and cancer cell lines

Cytogenetic and genome research, 1999-01, Vol.85 (3-4), p.217-220

1999

Volltextzugriff (PDF)

Preclinical evaluation of CPT-11 and its active metabolite SN-38

Seminars in oncology, 1996-02, Vol.23 (1 Suppl 3), p.11

1996

Volltextzugriff (PDF)

Synthesis and Structure-Activity Relationships of New Antitumor Taxoids. Effects of Cyclohexyl Substitution at the C-3' and/or C-2 of Taxotere (Docetaxel)

Journal of medicinal chemistry, 1994-08, Vol.37 (16), p.2602-2608

1994

Volltextzugriff (PDF)

Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer

Annals of oncology, 1993-04, Vol.4 (4), p.321-324

1993

Volltextzugriff (PDF)

Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts : lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin

Cancer research (Chicago, Ill.), 1993-06, Vol.53 (12), p.2823-2829

1993

Volltextzugriff (PDF)

RPR 130401, a Nonpeptidomimetic Farnesyltransferase Inhibitor with in Vivo Activity

Annals of the New York Academy of Sciences, 1999-01, Vol.886 (1), p.249-251

1999

Volltextzugriff (PDF)

Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere®)

Investigational new drugs, 1995-01, Vol.13 (1), p.1-11

1995

Volltextzugriff (PDF)

Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents

European journal of cancer (1990), 1993, Vol.29 (14), p.2009-2014

1993

Volltextzugriff (PDF)

Influence of microtubule-associated proteins on the differential effects of paclitaxel and docetaxel

Journal of protein chemistry, 1996-05, Vol.15 (4), p.377-388

1996

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(65)

Sprache

Englisch
(63)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Animals
(49)
Mice
(44)
Life Sciences & Biomedicine
(42)
Science & Technology
(42)
Biological And Medical Sciences
(38)
Medical Sciences
(37)
Antineoplastic Agents
(35)
Pharmacology. Drug Treatments
(35)
Oncology
(32)
Humans
(26)
Female
(22)
Male
(21)
Chemotherapy
(20)
Pharmacology & Pharmacy
(19)
Taxoids
(19)
Paclitaxel - Analogs & Derivatives
(17)
Docetaxel
(15)
Neoplasms, Experimental - Drug Therapy
(15)
Antineoplastic Agents, Phytogenic - Therapeutic Use
(14)
General Aspects
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel

Preclinical evaluation of new taxoids

Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma

Docetaxel (Taxotere®) a review of preclinical and clinical experience. Part I: preclinical experience

Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue

Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination

Preclinical pharmacology of docetaxel

Syntheses and Structure−Activity Relationships of the Second-Generation Antitumor Taxoids: Exceptional Activity against Drug-Resistant Cancer Cells

Preclinical evaluation of docetaxel (Taxotere)

Preclinical profile of docetaxel (taxotere): efficacy as a single agent and in combination

Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts

Tau expression in model adenocarcinomas correlates with docetaxel sensitivity in tumour-bearing mice

Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

Docetaxel chronopharmacology in mice

Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice

Proteolysis of microtubule associated protein 2 and sensitivity of pancreatic tumours to docetaxel

A novel human gene, encoding a potential membrane protein conserved from yeast to man, is strongly expressed in testis and cancer cell lines

Preclinical evaluation of CPT-11 and its active metabolite SN-38

Synthesis and Structure-Activity Relationships of New Antitumor Taxoids. Effects of Cyclohexyl Substitution at the C-3' and/or C-2 of Taxotere (Docetaxel)

Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer

Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts : lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin

RPR 130401, a Nonpeptidomimetic Farnesyltransferase Inhibitor with in Vivo Activity

Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere®)

Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents

Influence of microtubule-associated proteins on the differential effects of paclitaxel and docetaxel

Suchergebnisse filtern